Acarix: Influx of news ahead of Q1 - Redeye

Redeye leaves its comments following a few press releases from Acarix in the past few days. The news included adoption of a new business model, revising its financial targets, initiation of a US clinical study, and a new health economic analysis of CADScor presented at the ACC.

Länk till analysen i sin helhet: https://www.redeye.se/research/995517/acarix-influx-of-news-ahead-of-q1?utm_source=finwire&utm_medium=RSS